SYNLawn Welcomes Romania’s First Official SYNLawn Distributor
POPEŞTI-LEORDENI, RO / ACCESS Newswire / April 27, 2025 / SYNLawn, a global manufacturer and innovator of bio-based synthetic turf, announced its expansion into a new international market with the launch SYNLawn Romania. The company will carry SYNLawn's premium line of synthetic turf and surfacing products as the first official and exclusive distributor in Romania.
"Our newest official partner is dedicated to bringing premium artificial turf solutions to the Romanian market," said George Neagle, president of SYNLawn Global. "With a strong focus on landscaping, golf, and commercial applications, SYNLawn Romania is set to redefine outdoor spaces in its region with high-quality, durable, and environmentally friendly artificial grass."
The company started its business in 2022 and is based in Popești-Leordeni, just 9 kilometers from Bucharest. SYNLawn Romania specializes in the distribution of premium landscaping products. While new to the artificial turf sector, the company has a solid foundation in sales and has already established strong partnerships with professional landscapers and installation experts across the country.
"We aim to inspire and educate our clients and partners to discover the benefits of high-quality artificial turf that adds value to every space," said Alin Stanciu, the owner of SYNLawn Romania. "The Romanian artificial turf market is currently dominated by low-cost products of lesser quality, so we plan to change that by introducing our clients and partners to premium artificial grass solutions that offer superior durability, aesthetic appeal, sustainability and long-term value. SYNLawn is not just a product; it's a vision for the future of outdoor landscaping."
SYNLawn Romania has already planned multiple residential landscaping projects and is actively working to penetrate the private sports and commercial landscaping market. Unlike state-funded sports projects that often prioritize cost over quality, SYNLawn Romania is dedicated to delivering high-performance synthetic turf for agility areas, golf courses, and commercial landscapes that require longevity, safety, and aesthetic excellence.
To provide clients with an interactive experience, SYNLawn Romania plans to open a showroom, allowing customers to see and feel SYNLawn's artificial grass in real-life conditions. Additionally, the company is actively participating in trade fairs and specialized landscaping events and fostering valuable connections with industry professionals, developers, and architects.
SYNLawn Romania is committed to serving clients in Romania with future plans to expand into Bulgaria and the Republic of Moldova. By developing a network of local partners, the company ensures efficient delivery and expert installation of SYNLawn's innovative synthetic grass solutions.
SYNLawn Romania is located at Strada Orizontului 110, Popești-Leordeni, Ilfov, Romania. Visit synlawn.ro for more information about the expert services and products offered by the team. Contact SYNLawn Romania by phone at +40 756 095 559, or email at contact@synlawn-romania.ro. Learn more about SYNLawn and its premium line of artificial turf products at SYNLawn.com.
About SYNLawn®
For more than 20 years, SYNLawn® has led the industry as the largest manufacturer and unrivaled innovator of artificial grass and synthetic surfacing. As part of the Sport Group Holding® family of companies, SYNLawn delivers the best products available on the market. SYNLawn's product offerings also include Calico Greens™, an upscale line of artificial wall displays. SYNLawn's turnkey network of over 120 distributors seamlessly combines environmental stewardship with industry-leading innovations. SYNLawn uses PCR content and bio-based ingredients, such as soy and sugarcane, and consumer-conscious additives, such as antimicrobials, to meet customers' wide range of needs. With more than 350,000 residential and commercial installations, the company is raising the bar for global synthetic turf standards and transforming the idea of grass. We have an award-winning, proprietary system with a large percentage of renewable content. From rooftops to road medians and rocket-launch viewing sites, SYNLawn has installed over 150 million square feet of U.S. soy-backed grass in the United States of America and over 30 other countries since 2008. SYNLawn added more soy than ever to its products in 2021. For more information visit www.SYNLawn.com and follow on Facebook, Instagram, LinkedIn, Pinterest and YouTube.
# # #
Contact Information
Mackenzie Smith
mackenzie@labearcommunications.com
574-524-5916
SOURCE: SYNLawn
View the original press release on ACCESS Newswire
SYNLawn
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
SK tes Launches New Circular IT Facility in Shannon, Expanding Ireland’s Role in Global Sustainable Tech Services24.4.2025 09:30:00 CEST | Press release
SHANNON, IE / ACCESS Newswire / April 24, 2025 / SK tes, a global leader in sustainable IT asset disposition (ITAD) and technology lifecycle services, has announced plans to open a new 36,000 square foot purpose-built facility in Shannon, marking a major vote of confidence in Ireland's thriving data and technology sector. The new facility will deliver comprehensive ITAD, data center decommissioning, and technology lifecycle management services to some of Ireland's largest enterprises, including hyperscale data center operators, while supporting national sustainability and circular economy goals. It will also create over 25 skilled jobs in one of the country's fastest-growing tech regions. "Ireland is at the forefront of Europe's digital economy, and our investment in Shannon reinforces our commitment to helping Irish companies manage technology securely, sustainably, and at scale," said Eric Ingebretsen, Chief Commercial Officer at SK tes. "This facility will allow us to meet the uniqu
Sauce Labs Launches Industry-First Enterprise Scale iOS 18 Testing on Sauce Labs Virtual Device Cloud, Boosting Test Speeds up to 40%24.4.2025 08:00:00 CEST | Press release
Leading test automation platform, powering development for over 300,000 active users and having executed more than 8 billion tests, enables developers and QA teams to ensure app quality on Apple's latest OS with unprecedented performance and scale. SAN FRANCISCO, CA / ACCESS Newswire / April 24, 2025 / Sauce Labs Inc., the leading platform for continuous quality, trusted by dev teams around the world to deliver apps users love, today announced the general availability of iOS 18 testing on its Virtual Device Cloud (VDC). Leveraging its new, high-performance Apple Silicon cloud infrastructure, Sauce Labs offers the market's most scalable enterprise-ready solution for automated mobile app and web testing on iOS 17.5, iOS 18, and beyond, enabling teams to execute tests up to 40% faster compared to previous versions. This launch addresses the critical need for timely testing support driven by Apple's transition to its proprietary Apple Silicon architecture and the rapid adoption rate of new
Introducing NUGEN(R) HLD-CD by Arxada: A Game-Changer in Healthcare Disinfection24.4.2025 07:00:00 CEST | Press release
Delivering Effective Germ Control in Five Minutes BASEL, CH / ACCESS Newswire / April 24, 2025 / Arxada, a global leader in specialty chemicals and innovative solutions, announces the launch of NUGEN® HLD-CD, a revolutionary healthcare disinfectant. This game-changing solution disinfects medical devices in just five minutes, ensuring that even the most resilient microorganisms, which can withstand harsh conditions, are destroyed.* NUGEN® HLD-CD is designed to meet the rigorous demands of healthcare environments. Its broad efficacy spectrum and short contact times make it suitable for all critical areas, including operating rooms, isolation areas, and intensive care units where speed and safety are essential. "We are excited to introduce NUGEN® HLD-CD to the healthcare market," said Uwe Holland, Head of Professional Hygiene EMEA at Arxada. "This solution is a game-changer in disinfection technology for healthcare facilities, providing professionals with a powerful means to improve patie
TCL Introduces the TCL T6C-UK Fire TV Series with QLED 4K, HDR PRO, and Freely23.4.2025 07:30:00 CEST | Press release
LONDON, UNITED KINGDOM / ACCESS Newswire / April 23, 2025 / TCL, the leading consumer electronics brand and the world's second-largest TV brand as well as an official sponsor of the Olympic Games, is proud to announce the launch of its highly anticipated T6C-UK TV series. The new range offers screen sizes from 43" to 85", ensuring there is a perfect option for every home. Featuring QLED technology, 4K resolution, and an intuitive Fire TV experience, the T6C-UK series offers exceptional picture quality, seamless content access, and smart functionality. The TCL T6C-UK series comes Freely-enabled, offering a seamless way to enjoy live and on-demand TV - all in one place and completely free. With Freely built-in, users can access their favourite streaming apps at the click of a button, eliminating the need to switch between platforms. From major channels to must-watch shows, everything is easily accessible from a single, intuitive home screen. Powered by Fire TV, the T6C-UK series also fea
BioNxt Solutions Prepares for Human Bioequivalence Study For MS23.4.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to report advanced preparation for its human bioequivalence study for its lead Multiple Sclerosis (MS) treatment. BioNxt's lead product, BNT23001, is a proprietary sublingual thin-film formulation of Cladribine for the treatment of MS. Preclinical studies, as reported in internal research data and third-party evaluations, have demonstrated high absorption rates and bioequivalence compared to existing oral tablet therapies. The Company has purchased Cladribine active pharmaceutical ingredient which is necessary to complete the technology transfer process with Gen-Plus, its European Contract Research and Development Organization (CRDO), in Munich, Germany. Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom